JP Morgan Chase’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.6M Buy
557,836
+97,831
+21% +$5.7M ﹤0.01% 1720
2025
Q4
$27.3M Sell
460,005
-139,043
-23% -$7.57M ﹤0.01% 1809
2025
Q3
$32.4M Sell
599,048
-48,324
-7% -$2.76M ﹤0.01% 1709
2025
Q2
$35.6M Sell
647,372
-569,774
-47% -$33.6M ﹤0.01% 1543
2025
Q1
$86M Sell
1,217,146
-328,510
-21% -$22.1M 0.01% 1004
2024
Q4
$102M Sell
1,545,656
-1,266,133
-45% -$84.8M 0.01% 928
2024
Q3
$198M Buy
2,811,789
+218,608
+8% +$18.3M 0.02% 692
2024
Q2
$213M Buy
2,593,181
+171,179
+7% +$14.3M 0.02% 633
2024
Q1
$212M Sell
2,422,002
-25,790
-1% -$2.31M 0.02% 634
2023
Q4
$236M Sell
2,447,792
-171,040
-7% -$15.1M 0.02% 572
2023
Q3
$232M Buy
2,618,832
+7,515
+0.3% +$669K 0.03% 513
2023
Q2
$226M Buy
2,611,317
+57,391
+2% +$5.4M 0.03% 526
2023
Q1
$248M Sell
2,553,926
-6,718
-0.3% -$696K 0.03% 479
2022
Q4
$265M Buy
2,560,644
+506,252
+25% +$47.5M 0.04% 429
2022
Q3
$174M Buy
2,054,392
+439,075
+27% +$39.1M 0.03% 528
2022
Q2
$134M Buy
1,615,317
+24,508
+2% +$1.95M 0.02% 639
2022
Q1
$123M Buy
1,590,809
+296,868
+23% +$24.8M 0.02% 758
2021
Q4
$114M Sell
1,293,941
-1,635,035
-56% -$135M 0.01% 826
2021
Q3
$226M Sell
2,928,976
-826,403
-22% -$65.2M 0.03% 537
2021
Q2
$313M Buy
3,755,379
+919,767
+32% +$72.9M 0.04% 472
2021
Q1
$214M Buy
2,835,612
+353,531
+14% +$28.9M 0.03% 551
2020
Q4
$218M Sell
2,482,081
-737,788
-23% -$58.5M 0.04% 501
2020
Q3
$245M Buy
3,219,869
+429,959
+15% +$43.5M 0.05% 415
2020
Q2
$344M Buy
2,789,910
+174,900
+7% +$17.4M 0.07% 287
2020
Q1
$221M Buy
2,615,010
+773,068
+42% +$66.6M 0.06% 338
2019
Q4
$156M Buy
1,841,942
+1,301,029
+241% +$98.3M 0.03% 512
2019
Q3
$36.5M Sell
540,913
-206,645
-28% -$15.9M 0.01% 1127
2019
Q2
$62.8M Sell
747,558
-102,872
-12% -$8.8M 0.01% 863
2019
Q1
$75.5M Sell
850,430
-310,002
-27% -$28.7M 0.02% 764
2018
Q4
$98.8M Sell
1,160,432
-247,433
-18% -$23.5M 0.02% 629
2018
Q3
$137M Buy
1,407,865
+201,425
+17% +$20.1M 0.03% 575
2018
Q2
$114M Buy
1,206,440
+151,058
+14% +$13.2M 0.03% 608
2018
Q1
$85.6M Sell
1,055,382
-527,403
-33% -$45.3M 0.02% 702
2017
Q4
$141M Buy
1,582,785
+102,061
+7% +$8.87M 0.03% 516
2017
Q3
$138M Sell
1,480,724
-179,395
-11% -$15.9M 0.03% 517
2017
Q2
$151M Sell
1,660,119
-547,061
-25% -$49.8M 0.04% 475
2017
Q1
$194M Sell
2,207,180
-1,030,288
-32% -$91.7M 0.05% 415
2016
Q4
$268M Sell
3,237,468
-463,593
-13% -$39.9M 0.07% 307
2016
Q3
$343M Buy
3,701,061
+325,518
+10% +$30.7M 0.09% 253
2016
Q2
$263M Sell
3,375,543
-1,110,895
-25% -$94.4M 0.07% 309
2016
Q1
$370M Sell
4,486,438
-1,144,155
-20% -$93.1M 0.1% 241
2015
Q4
$590M Buy
5,630,593
+472,390
+9% +$49.3M 0.16% 162
2015
Q3
$543M Buy
5,158,203
+2,438,282
+90% +$326M 0.15% 165
2015
Q2
$372M Buy
2,719,921
+1,174,260
+76% +$146M 0.09% 259
2015
Q1
$193M Buy
1,545,661
+991,462
+179% +$105M 0.05% 431
2014
Q4
$50.1M Buy
554,199
+62,328
+13% +$5.18M 0.01% 931
2014
Q3
$35.5M Sell
491,871
-366,348
-43% -$24.1M 0.01% 1096
2014
Q2
$53.4M Sell
858,219
-65,828
-7% -$3.98M 0.01% 824
2014
Q1
$63M Buy
924,047
+592,150
+178% +$43.6M 0.02% 700
2013
Q4
$23.3M Sell
331,897
-66,925
-17% -$4.55M 0.01% 1232
2013
Q3
$28.8M Sell
398,822
-418,202
-51% -$27.8M 0.01% 1106
2013
Q2
$45.5M Buy
+817,024
New +$50.9M 0.02% 787

Other funds holding BMRN